|
1
|
Xiao PL, Cui AY, Hsu CJ, Peng R, Jiang N,
Xu XH, Ma YG, Liu D and Lu HD: Global, regional prevalence, and
risk factors of osteoporosis according to the World Health
Organization diagnostic criteria: A systematic review and
meta-analysis. Osteoporos Int. 33:2137–2153. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnell O and Kanis J: An estimate of the
worldwide prevalence and disability associated with osteoporotic
fractures. Osteoporos Int. 17:1726–1733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Consensus Development Conference, .
Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med.
94:646–650. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cooper C, Campion G and Melton L III: Hip
fractures in the elderly: A world-wide projection. Osteoporos Int.
2:285–289. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aghebati-Maleki L, Dolati S, Zandi R,
Fotouhi A, Ahmadi M, Aghebati A, Nouri M, Kazem Shakouri S and
Yousefi M: Prospect of mesenchymal stem cells in therapy of
osteoporosis: A review. J Cell Physiol. 234:8570–8578. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su P, Tian Y, Yang C, Ma X, Wang X, Pei J
and Qian A: Mesenchymal stem cell migration during bone formation
and bone diseases therapy. Int J Mol Sci. 19:23432018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wossidlo M, Nakamura T, Lepikhov K,
Marques CJ, Zakhartchenko V, Boiani M, Arand J, Nakano T, Reik W
and Walter J: 5-Hydroxymethylcytosine in the mammalian zygote is
linked with epigenetic reprogramming. Nat Commun. 2:2412011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome-biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clancy MJ, Shambaugh ME, Timpte CS and
Bokar JA: Induction of sporulation in Saccharomyces cerevisiae
leads to the formation of N6-methyladenosine in mRNA: A potential
mechanism for the activity of the IME4 gene. Nucleic Acids Res.
30:4509–4518. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krug RM, Morgan MA and Shatkin AJ:
Shatkin, Influenza viral mRNA contains internal N6-methyladensine
and 5′-terminal 7-methylguanosine in cap structures. J Virol.
20:45–53. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi B, Liu WW, Yang K, Jiang GM and Wang
H: The role, mechanism, and application of RNA methyltransferase
METTL14 in gastrointestinal cancer. Mol Cancer. 21:1632022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malavika D, Shreya S, Priya V, Rohini M,
He Z, Partridge NC and Selvamurugan N: miR-873-3p targets HDAC4 to
stimulate matrix metalloproteinase-13 expression upon parathyroid
hormone exposure in rat osteoblasts. J Cell Physiol. 235:7996–8009.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Xue Q, Wang D, Du M, Zhang Y and
Gao S: MiR-873 induces lung adenocarcinoma cell proliferation and
migration by targeting SRCIN1. Am J Transl Res. 7:2519–2526.
2016.PubMed/NCBI
|
|
15
|
Gong H, Fang L, Li Y, Du J, Zhou B, Wang
X, Zhou H, Gao L, Wang K and Zhang J: miR-873 inhibits colorectal
cancer cell proliferation by targeting TRAF5 and TAB1. Oncol Rep.
39:1090–1098. 2018.PubMed/NCBI
|
|
16
|
Zhang JS, Zhao Y, Lv Y, Liu PY, Ruan JX,
Sun YL, Gong TX, Wan N and Qiu GR: miR-873 suppresses H9C2
cardiomyocyte proliferation by targeting GLI1. Gene. 626:426–432.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W,
Xie ZG, Shi L, He X, Jin SG, et al: The role of Tet3 DNA
dioxygenase in epigenetic reprogramming by oocytes. Nature.
477:606–610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao X, Yang Y, Sun BF, Shi Y, Yang X,
Xiao W, Hao YJ, Ping XL, Chen YS, Wang WJ, et al: FTO-dependent
demethylation of N6-methyladenosine regulates mRNA splicing and is
required for adipogenesis. Cell Res. 24:1403–1419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH,
Wang F, Wang TT, Xu QG, Zhou WP and Sun SH: METTL14 suppresses the
metastatic potential of hepatocellular carcinoma by modulating
N6-methyladenosine-dependent primary MicroRNA processing.
Hepatology. 65:529–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng Z, Li Q, Meng R, Yi B and Xu Q:
METTL3 regulates alternative splicing of MyD88 upon the
lipopolysaccharide-induced inflammatory response in human dental
pulp cells. J Cell Mol Med. 22:2558–2568. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin S, Choe J, Du P, Triboulet R and
Gregory RI: The m(6)A Methyltransferase METTL3 Promotes Translation
in Human Cancer Cells. Molecular Cell. 62:335–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
